Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-02 4:12 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 34,501 | $27.02 | $932,260 | 218,809 (Indirect Direct) | View |
| 2026-10-01 Sale | 2026-10-02 4:09 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,141 | $26.93 | $434,743 | 144,521 (Direct) | View |
| 2026-09-29 Sale | 2026-10-01 4:06 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $27.06 | $202,921 | 38,959 (Direct) | View |
| 2026-09-04 Sale | 2026-09-08 4:20 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 9,705 | $26.22 | $254,502 | 0 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:27 pm | Maze Therapeutics Inc. | MAZE | Courtney Phillips GC and Corp. Secretary | 3,993 | $26.24 | $104,766 | 7,007 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:25 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 6,434 | $26.24 | $168,811 | 32,316 (Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:24 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 22,638 | $26.24 | $593,955 | 268,868 (Indirect Direct) | View |
| 2026-09-02 Sale | 2026-09-04 4:22 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 10,295 | $26.24 | $270,111 | 9,705 (Direct) | View |
| 2026-09-01 Sale | 2026-09-03 4:27 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 34,501 | $26.29 | $906,999 | 323,355 (Indirect Direct) | View |
| 2026-09-01 Sale | 2026-09-03 4:24 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,141 | $26.36 | $425,512 | 200,662 (Direct) | View |
| 2026-08-28 Sale | 2026-08-31 6:32 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $27.58 | $206,824 | 40,393 (Direct) | View |
| 2026-08-13 Sale | 2026-08-14 4:54 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,142 | $27.61 | $445,621 | 176,803 (Direct) | View |
| 2026-08-03 Sale | 2026-08-05 4:08 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 34,501 | $26.73 | $922,315 | 255,263 (Indirect) | View |
| 2026-07-29 Sale | 2026-07-31 4:15 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $27.34 | $205,031 | 47,893 (Direct) | View |
| 2026-07-01 Sale | 2026-07-02 4:29 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,609 | $29.9 | $436,864 | 192,945 (Direct) | View |
| 2026-07-01 Sale | 2026-07-02 4:28 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 34,501 | $29.98 | $1,034,253 | 287,171 (Indirect) | View |
| 2026-06-29 Sale | 2026-07-01 4:17 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $28.02 | $210,150 | 55,393 (Direct) | View |
| 2026-06-22 Sale | 2026-06-24 4:14 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 27,858 | $26.04 | $725,495 | 319,079 (Indirect) | View |
| 2026-06-01 Sale | 2026-06-03 5:04 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 6,643 | $26.2 | $174,048 | 27,970 (Indirect) | View |
| 2026-06-01 Sale | 2026-06-03 5:01 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $25.66 | $381,112 | 207,554 (Direct) | View |
| 2026-05-29 Sale | 2026-06-02 4:12 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $26.34 | $197,554 | 61,451 (Direct) | View |
| 2026-05-22 Sale | 2026-05-27 4:16 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 32,564 | $26.01 | $847,048 | 350,987 (Indirect) | View |
| 2026-05-15 Sale | 2026-05-18 5:07 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 1,938 | $26 | $50,388 | 31,001 (Indirect) | View |
| 2026-05-14 Sale | 2026-05-18 5:03 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $26.22 | $393,354 | 222,407 (Direct) | View |
| 2026-04-29 Sale | 2026-05-01 4:18 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $25.37 | $190,299 | 54,646 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 4:08 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $29.46 | $441,904 | 237,407 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-01 Exercise | 2026-10-02 4:09 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,141 | $0 | 144,521 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-02 4:09 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,141 | $10.42 | 144,521 (Direct) | View |
| 2026-09-29 Exercise | 2026-10-01 4:06 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 38,959 (Direct) | View |
| 2026-09-29 Exercise | 2026-10-01 4:06 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 38,959 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:31 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Courtney Phillips GC and Corp. Secretary | 11,000 | $0 | 22,000 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:29 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 12,500 | $0 | 51,250 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:27 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 50,000 | $0 | 323,355 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:24 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 36,141 | $0 | 200,662 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:24 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,141 | $10.42 | 200,662 (Direct) | View |
| 2026-08-28 Exercise | 2026-08-31 6:32 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 40,393 (Direct) | View |
| 2026-08-28 Exercise | 2026-08-31 6:32 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 40,393 (Direct) | View |
| 2026-08-13 Option Award | 2026-08-17 4:52 pm | N/A 2036-08-12 | Maze Therapeutics Inc. | MAZE | Kornowski Sophie Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2026-08-13 Option Award | 2026-08-17 4:51 pm | N/A 2036-08-12 | Maze Therapeutics Inc. | MAZE | Johnson Paula A Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 4:54 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,142 | $0 | 176,803 (Direct) | View |
| 2026-08-13 Exercise | 2026-08-14 4:54 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 16,142 | $10.42 | 176,803 (Direct) | View |
| 2026-07-29 Exercise | 2026-07-31 4:15 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 47,893 (Direct) | View |
| 2026-07-29 Exercise | 2026-07-31 4:15 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 47,893 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 4:29 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,609 | $0 | 192,945 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 4:29 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,609 | $10.42 | 192,945 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 4:17 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 55,393 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 4:17 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 55,393 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:31 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | SPIEGELMAN DANIEL K Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:30 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | SCHELLER RICHARD H Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:28 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:26 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Hoppenot Herve Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:25 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:23 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Andrews Nancy C Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 5:01 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $0 | 207,554 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 5:01 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $10.42 | 207,554 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-02 4:12 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 61,451 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-02 4:12 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 61,451 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 5:03 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 222,407 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 5:03 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 222,407 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 4:15 pm | N/A 2032-03-15 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 14,305 | $0 | 72,737 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 4:15 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 14,305 | $10.42 | 72,737 (Direct) | View |
| 2026-05-04 Gift | 2026-05-06 4:13 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 7,422 | $0 | 31,113 (Direct) | View |
| 2026-04-29 Exercise | 2026-05-01 4:18 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 54,646 (Direct) | View |
| 2026-04-29 Exercise | 2026-05-01 4:18 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 54,646 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:08 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 237,407 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:08 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 237,407 (Direct) | View |